Injectable and strong nano-apatite scaffolds for cell/growth factor delivery and bone regeneration

Dental Materials

Volumn 24, Issue 9, 2008, Pages 1212-1222

  Xu, Hockin H K ^a   Weir, Michael D ^a   Simon, Carl G ^b  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

Author keywords

Bone tissue engineering; Calcium phosphate cement; Growth factor; Macroporous scaffolds; Nano apatite; Osteoblast cell delivery; Stress bearing

Indexed keywords

BONE; BONE CEMENT; CALCIUM; CEMENTS; PHOSPHATE MINERALS; SCAFFOLDS;

(I ,J) CONDITIONS; BONE FRACTURES; BONE REGENERATION; CALCIUM PHOSPHATE CEMENT (CPC); COMPOSITE SCAFFOLDS; GROWTH FACTORS; IN-SITU; NANO APATITE; OSTEOGENIC CELLS; TETRACALCIUM PHOSPHATE (TTCP);

CALCIUM PHOSPHATE;

ALGINIC ACID; APATITE; BIOMATERIAL; BIOPOLYMER; BONE CEMENT; CALCIUM PHOSPHATE; CHITOSAN; DICALCIUM PHOSPHATE ANHYDROUS; MANNITOL; NANOMATERIAL; TETRACALCIUM PHOSPHATE; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; BONE REGENERATION; CELL ADHESION; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CELL STRAIN 3T3; CELL SURVIVAL; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG DELIVERY SYSTEM; DRUG EFFECT; HYDROGEL; MOUSE; OSTEOBLAST; PHYSIOLOGY; POROSITY;

3T3 CELLS; ALGINATES; ANIMALS; APATITES; BIOCOMPATIBLE MATERIALS; BIOPOLYMERS; BONE CEMENTS; BONE REGENERATION; CALCIUM PHOSPHATES; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CHITOSAN; DRUG DELIVERY SYSTEMS; HYDROGEL; MANNITOL; MICE; MODELS, BIOLOGICAL; NANOSTRUCTURES; OSTEOBLASTS; POROSITY; TISSUE SCAFFOLDS;

EID: 47249118349     PISSN: 01095641     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dental.2008.02.001     Document Type: Article

References (56)

1. Praemer A, Furner S, Rice DP. Musculoskeletal conditions in the United States. Rosemont: Amer Acad Orthop Surg; 1999 [chapter 1].
2. Franceshi R.T. Biological approaches to bone regeneration by gene therapy. Crit Rev Oral Biol Med 84 (2005) 1093-1103
3. Medical Data International. RP-651147-Orthopedic and musculoskeletal markets: Biotechnology and Tissue Engineering. 2000; p. 28-31.
4. Ambrosio A.M.A., Sahota J.S., Khan Y., and Laurencin C.T. A novel amorphous calcium phosphate polymer ceramic for bone repair. I. Synthesis and characterization. J Biomed Mater Res 58B (2001) 295-301
5. Laurencin C.T., Ambrosio A.M.A., Borden M.D., and Cooper J.A. Tissue engineering: orthopedic applications. Annu Rev Biomed Eng 1 (1999) 19-46
6. Hench L.L., and Polak J.M. Third-generation biomedical materials. Science 295 (2002) 1014-1017
7. An YH. Internal fixation in osteoporotic bone. New York, NY: Thieme Medical, 2002, Foreword.
8. Murphy W.L., Hsiong S., Richardson T.P., Simmons G.A., and Mooney D.J. Effects of a bone-like mineral film on phenotype of adult human mesenchymal stem cells in vitro. Biomaterials 26 (2005) 303-310
9. Livingston T., Ducheyne P., and Garino J. In vivo evaluation of a bioactive scaffold for bone tissue engineering. J Biomed Mater Res 62 (2002) 1-13
10. Ehara A., Ogata K., Imazato S., Ebisu S., Nakano T., and Umakoshi Y. Effects of alpha-TCP and TetCP on MC3T3-E1 proliferation, differentiation and mineralization. Biomaterials 24 (2003) 831-836
11. LeGeros R.Z. Biodegradation and bioresorption of calcium phosphate ceramics. Clin Mater 14 (1993) 65-88
12. Suchanek W., and Yoshimura M. Processing and properties of hydroxyapatite-based biomaterials for use as hard tissue replacement implants. J Mater Res 13 (1998) 94-117
13. Hing K.A., Best S.M., and Bonfield W. Characterization of porous hydroxyapatite. J Mater Sci: Mater Med 10 (1999) 135-145
14. Ducheyne P., and Qiu Q. Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function. Biomaterials 20 (1999) 2287-2303
15. Pilliar R.M., Filiaggi M.J., Wells J.D., Grynpas M.D., and Kandel R.A. Porous calcium polyphosphate scaffolds for bone substitute applications - in vitro characterization. Biomaterials 22 (2001) 963-972
16. Chu T.M.G., Orton D.G., Hollister S.J., Feinberg S.E., and Halloran J.W. Mechanical and in vivo performance of hydroxyapatite implants with controlled architectures. Biomaterials 23 (2002) 1283-1293
17. Foppiano S., Marshall S.J., Marshall G.W., Saiz E., and Tomsia A.P. The influence of novel bioactive glasses on in vitro osteoblast behavior. J Biomed Mater Res A 71 (2004) 242-249
18. Russias J., Saiz E., Deville S., Gryn K., Liu G., Nalla R.K., et al. Fabrication and in vitro characterization of three-dimensional organic/inorganic scaffolds by robocasting. J Biomed Mater Res A 83 (2007) 434-445
19. Brown W.E., and Chow L.C. A new calcium phosphate water setting cement. In: Brown P.W. (Ed). Cements research progress (1986), American Ceramic Society, Westerville, OH 352-379
20. Ginebra M.P., Fernandez E., De Maeyer E.A.P., Verbeeck R.M.H., Boltong M.G., Ginebra J., et al. Setting reaction and hardening of an apatite calcium phosphate cement. J Dent Res 76 (1997) 905-912
21. Ishikawa K., Miyamoto Y., Takechi M., Toh T., Kon M., Nagayama M., et al. Non-decay type fast-setting calcium phosphate cement: hydroxyapatite putty containing an increased amount of sodium alginate. J Biomed Mater Res 36 (1997) 393-399
22. Durucan C., and Brown P.W. Low temperature formation of calcium-deficient hydroxyapatite-PLA/PLGA composites. J Biomed Mater Res 51 (2000) 717-725
23. Barralet J.E., Gaunt T., Wright A.J., Gibson I.R., and Knowles J.C. Effect of porosity reduction by compaction on compressive strength and microstructure of calcium phosphate cement. J Biomed Mater Res B 63 (2002) 1-9
24. Shindo M.L., Costantino P.D., Friedman C.D., and Chow L.C. Facial skeletal augmentation using hydroxyapatite cement. Arch Otolaryngol Head Neck Surg 119 (1993) 185-190
25. Friedman C.D., Costantino P.D., Takagi S., and Chow L.C. BoneSource hydroxyapatite cement: a novel biomaterial for craniofacial skeletal tissue engineering and reconstruction. J Biomed Mater Res (Appl Biomater) 43 (1998) 428-432
26. Chow L.C. Calcium phosphate cements: chemistry, properties, and applications. Mater Res Symp Proc 599 (2000) 27-37
27. Brown G.D., Mealey B.L., Nummikoski P.V., Bifano S.L., and Waldrop T.C. Hydroxyapatite cement implant for regeneration of periodontal osseous defects in humans. J Periodontol 69 (1998) 146-157
28. Shors E.C., and Holmes R.E. Porous hydroxyapatite. In: Hench L.L., and Wilson J. (Eds). An introduction to bioceramics (1993), World Scientific, New Jersey 181-198
29. Xu H.H.K., and Quinn J.B. Calcium phosphate cement containing resorbable fibers for short-term reinforcement and macroporosity. Biomaterials 23 (2002) 193-202
30. Xu H.H.K., Quinn J.B., Takagi S., Chow L.C., and Eichmiller F.C. Strong and macroporous calcium phosphate cement: effects of porosity and fiber reinforcement on mechanical properties. J Biomed Mater Res 57 (2001) 457-466
31. Takagi S., and Chow L.C. Formation of macropores in calcium phosphate cement implants. J Mater Sci: Mater Med 12 (2001) 135-139
32. Xu H.H.K., and Simon C.G. Self-hardening calcium phosphate composite scaffold for bone tissue engineering. J Orthop Res 22 (2004) 535-543
33. Burguera E.F., Xu H.H.K., Takagi S., and Chow L.C. High early-strength calcium phosphate bone cement: effects of dicalcium phosphate dehydrate and absorbable fibers. J Biomed Mater Res A 75 (2005) 966-975
34. Burguera E.F., Xu H.H.K., and Weir M.D. Injectable and rapid-setting calcium phosphate bone cement with dicalcium phosphate dihydrate. J Biomed Mater Res B 77 (2006) 126-134
35. Xu H.H.K., Eichmiller F.C., and Giuseppetti A.A. Reinforcement of a self-setting calcium phosphate cement with different fibers. J Biomed Mater Res 52 (2000) 107-114
36. 4 composites at elevated temperatures. J Am Ceram Soc 78 (1995) 388-394
37. 4-matrix composites. J Am Ceram Soc 77 (1994) 1897-1900
38. Zhang Y., and Xu H.H.K. Effects of synergistic reinforcement and absorbable fiber strength on hydroxyapatite bone cement. J Biomed Mater Res 75A (2005) 832-840
39. Zhang Y., Xu H.H.K., Takagi S., and Chow L.C. In-situ hardening hydroxyapatite-based scaffold for bone repair. J Mater Sci: Mater Med 17 (2006) 437-445
40. International Standards Organization. ISO 10993-5. Biological evaluation of medical devices-Part 5: Tests for in vitro cytotoxicity. International Standards Organization, Geneva, Switzerland, 1999.
41. Simon Jr. C.G., Khatri C.A., Wight S.A., and Wang F.W. Preliminary report on the biocompatibility of a moldable, resorbable, composite bone graft consisting of calcium phosphate cement and poly(lactide-co-glycolide) microspheres. J Orthop Res 20 (2002) 473-482
42. Xu H.H.K., Smith D.T., and Simon Jr. C.G. Strong and bioactive composites containing nano-silica-fused whiskers for bone repair. Biomaterials 25 (2004) 4615-4626
43. Xu H.H.K., and Simon Jr. C.G. Fast setting calcium phosphate-chitosan scaffold: mechanical properties and biocompatibility. Biomaterials 26 (2005) 1337-1348
44. Boontheekul T., Kong H.J., and Mooney D.J. Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials 26 (2005) 2455-2465
45. Weir M.D., Xu H.H.K., and Simon C.G. Strong calcium phosphate cement-chitosan-mesh construct containing cell-encapsulating hydrogel beads for bone tissue engineering. J Biomed Mater Res A 77 (2006) 487-496
46. Lee D.D., Tofighi A., Aiolova M., Chakravarthy P., Catalano A., Majahad A., et al. α-BSM: A biomimetic bone substitute and drug delivery vehicle. Clin Orthop Res 367S (1999) S396-S405
47. Blom E.J., Klein-Nulend J., Wolke J.G.C., Kurashina K., van Waas M.A.J., and Burger E.H. Transforming growth factor-β1 incorporation in an β-tricalcium phosphate/dicalcium phosphate dehydrate/tetracalcium phosphate monoxide cement: release characteristics and physiochemical properties. Biomaterials 23 (2002) 1261-1268
48. Ruhe P.Q., Hedberg E.L., Padron N.T., Spauwen P.H.M., Jansen J.A., and Mikos A.G. rhBMP-2 release from injectable poly(dl-lactic-co-glycolic acid)/calcium-phosphate cement composites. J Bone Joint Surg 85 (2003) 75-81
49. Huang Y.C., Kaigler D., Rice K.G., Krebsbach P.H., and Mooney D.J. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 20 (2005) 848-857
50. Isobe M., Yamazaki Y., Mori M., Ishihara K., Nakabayashi N., and Amagasa T. The role of recombinant human bone morphogenetic protein-2 in PLGA capsules at an extraskeletal site of the rat. J Biomed Mater Res 45 (1999) 36-41
51. Paralkar V.M., Hammonds R.G., and Reddi A.H. Identification and characterization of cellular binding proteins (receptors) for recombinant human bone morphogenetic protein 2B, an initiator of bone differentiation cascade. Proc Natl Acad Sci USA 15 88 (1991) 3397-3401
52. R&D Systems. www.RnDSystems.com. Recombinant human BMP-2: Specifications and use. Catalog number: 355-BM, 2005.
53. Weir MD, Xu HHK. High-strength, in situ-setting calcium phosphate composite with protein release. J Biomed Mater Res, in press.
54. Seeherman H., and Wozney J.M. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 16 (2005) 329-345
55. Cunningham N.S., Paralkar V., and Reddi A.H. Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proc Natl Acad Sci USA 89 (1992) 11740-11744
56. Kim H.D., Wozney J.M., and Li R.H. Characterization of a calcium phosphate-based matrix for rhBMP-2. Methods Mol Biol 238 (2004) 49-64